Marshall Wace’s Nanobiotix NBTX Stock Holding History

Marshall Wace’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$285K	Sell	9,239 -261	-3%	-$6.88K	﹤0.01%	2665
2025 Q4	$220K	Buy	+9,500	New	+$208K	﹤0.01%	2562

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Marshall Wace's NBTX Position: Q1 2026 in Review

Marshall Wace reduced its Nanobiotix (NBTX) stake by 2.7% in Q1 2026, selling an estimated $6.88K and leaving 9,239 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #2665.

Marshall Wace first reported a position in NBTX in Q4 2025 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold NBTX as of Q1 2026.

Marshall Wace held 9,239 shares of Nanobiotix worth $285K as of Q1 2026.
Marshall Wace sold 261 Nanobiotix shares in Q1 2026, an estimated $6.88K.
Nanobiotix made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2665 holding.
Marshall Wace first reported a position in Nanobiotix in Q4 2025 and has held it in 2 quarters since.
15 funds tracked by Wall St. Rank held Nanobiotix as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.